ecancer catches up with Josep Tabernero on exploring new targets in GI cancer as well as the WIN Consortium launch of WINTHER, an original academic and international clinical trial

In two recent interviews with ecancer Josep Tabernero highlights key studies and promising data presented at the ESMO 14th World Congress on Gastrointestinal Cancer (WCGC), Barcelona, 27 – 30 June 2012, as well as discusses the WIN Consortium (Worldwide Innovative Networking in personalized cancer medicine) launch of WINTHER: The WIN therapeutics clinical trial.

Click here to listen to Josep Tabernero´s selection of highlights from the ESMO 14th World Congress on Gastrointestinal Cancer.

To discover more about the WIN therapeutics original academic and international clinical trial click here.

Related Posts